{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:52:26Z","timestamp":1770749546383,"version":"3.50.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovation Cultivation Fund PLA General Hospital Sixth Medical Center","award":["CXPY202205"],"award-info":[{"award-number":["CXPY202205"]}]},{"name":"Medical Science Research Project of Hebei","award":["20220104"],"award-info":[{"award-number":["20220104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15535-5","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:35:23Z","timestamp":1768361723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["T-cell exhaustion indicator characterizes the tumor microenvironment landscape and predicts colon adenocarcinoma prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing"],"prefix":"10.1186","volume":"26","author":[{"given":"Haifeng","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaowei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenya","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaofan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"4","key":"15535_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391. https:\/\/doi.org\/10.1136\/gutjnl-2015-310912.","journal-title":"Gut"},{"issue":"2","key":"15535_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"15535_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/jso.20915","volume":"96","author":"MG Mutch","year":"2007","unstructured":"Mutch MG. Molecular profiling and risk stratification of adenocarcinoma of the colon. J Surg Oncol. 2007;96(8):693\u2013703. https:\/\/doi.org\/10.1002\/jso.20915.","journal-title":"J Surg Oncol"},{"key":"15535_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1200\/EDBK_200961","volume":"38","author":"MJ Hall","year":"2018","unstructured":"Hall MJ, Morris AM, Sun W. Precision medicine versus population medicine in colon cancer: from prospects of prevention, adjuvant chemotherapy, and surveillance. Am Soc Clin Oncol Educ Book. 2018;38:220\u201330. https:\/\/doi.org\/10.1200\/EDBK_200961.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"4","key":"15535_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/jmcb\/mjy075","volume":"11","author":"M Nakayama","year":"2019","unstructured":"Nakayama M, Oshima M. Mutant p53 in colon cancer. J Mol Cell Biol. 2019;11(4):267\u201376. https:\/\/doi.org\/10.1093\/jmcb\/mjy075.","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"15535_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","volume":"42","author":"A Baessler","year":"2024","unstructured":"Baessler A, Vignali DAA. T cell exhaustion. Annu Rev Immunol. 2024;42(1):179\u2013206. https:\/\/doi.org\/10.1146\/annurev-immunol-090222-110914.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"15535_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","volume":"20","author":"A Kallies","year":"2020","unstructured":"Kallies A, Zehn D, Utzschneider DT. Precursor exhausted T cells: key to successful immunotherapy? Nat Rev Immunol. 2020;20(2):128\u201336. https:\/\/doi.org\/10.1038\/s41577-019-0223-7.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"15535_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.immuni.2009.06.019","volume":"31","author":"H Shin","year":"2009","unstructured":"Shin H, Blackburn SD, Intlekofer AM, Kao C, Angelosanto JM, Reiner SL, et al. A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity. 2009;31(2):309\u201320. https:\/\/doi.org\/10.1016\/j.immuni.2009.06.019.","journal-title":"Immunity"},{"issue":"9","key":"15535_CR9","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41590-023-01569-z","volume":"24","author":"V Aggarwal","year":"2023","unstructured":"Aggarwal V, Workman CJ, Vignali DAA. LAG-3 as the third checkpoint inhibitor. Nat Immunol. 2023;24(9):1415\u201322. https:\/\/doi.org\/10.1038\/s41590-023-01569-z.","journal-title":"Nat Immunol"},{"issue":"2","key":"15535_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1302369","volume":"369","author":"JD Wolchok","year":"2013","unstructured":"Wolchok JD, Kluger H, Callahan MK, Postow MA, Rizvi NA, Lesokhin AM, et al. Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med. 2013;369(2):122\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1302369.","journal-title":"N Engl J Med"},{"issue":"5","key":"15535_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bulcan.2018.01.018","volume":"105","author":"F Liu","year":"2018","unstructured":"Liu F, Zeng G, Zhou S, He X, Sun N, Zhu X, et al. Blocking Tim-3 or\/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma. Bull Cancer. 2018;105(5):493\u2013501. https:\/\/doi.org\/10.1016\/j.bulcan.2018.01.018.","journal-title":"Bull Cancer"},{"issue":"1","key":"15535_CR12","doi-asserted-by":"publisher","first-page":"e000639","DOI":"10.1136\/jitc-2020-000639","volume":"8","author":"B Huang","year":"2020","unstructured":"Huang B, Liu R, Wang P, Yuan Z, Yang J, Xiong H, et al. CD8+CD57+ T cells exhibit distinct features in human non-small cell lung cancer. J Immunother Cancer. 2020;8(1):e000639. https:\/\/doi.org\/10.1136\/jitc-2020-000639.","journal-title":"J Immunother Cancer"},{"key":"15535_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/mdr2.70004","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang G, Xu P, Yu F, Li L, Huang R, et al. Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med Res. 2025;1:10\u201331. https:\/\/doi.org\/10.1002\/mdr2.70004.","journal-title":"Med Res"},{"key":"15535_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-1-0716-0301-7_7","volume":"2117","author":"CB Steen","year":"2020","unstructured":"Steen CB, Liu CL, Alizadeh AA, Newman AM. Profiling cell type abundance and expression in bulk tissues with CIBERSORTx. Methods Mol Biol. 2020;2117:135\u201357. https:\/\/doi.org\/10.1007\/978-1-0716-0301-7_7.","journal-title":"Methods Mol Biol"},{"issue":"10","key":"15535_CR15","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.4049\/jimmunol.169.10.5392","volume":"169","author":"CJ Workman","year":"2002","unstructured":"Workman CJ, Dugger KJ, Vignali DA. Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3. J Immunol. 2002;169(10):5392\u20135. https:\/\/doi.org\/10.4049\/jimmunol.169.10.5392.","journal-title":"J Immunol"},{"key":"15535_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/82_2010_114","volume":"344","author":"MV Goldberg","year":"2011","unstructured":"Goldberg MV, Drake CG. LAG-3 in cancer immunotherapy. Curr Top Microbiol Immunol. 2011;344:269\u201378. https:\/\/doi.org\/10.1007\/82_2010_114.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"15535_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4049\/jimmunol.174.2.688","volume":"174","author":"CJ Workman","year":"2005","unstructured":"Workman CJ, Vignali DA. Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). J Immunol. 2005;174(2):688\u201395. https:\/\/doi.org\/10.4049\/jimmunol.174.2.688.","journal-title":"J Immunol"},{"key":"15535_CR18","doi-asserted-by":"publisher","first-page":"101305","DOI":"10.1016\/j.smim.2019.101305","volume":"42","author":"E Ruffo","year":"2019","unstructured":"Ruffo E, Wu RC, Bruno TC, Workman CJ, Vignali DAA. Lymphocyte-activation gene 3 (LAG3): the next immune checkpoint receptor. Semin Immunol. 2019;42:101305. https:\/\/doi.org\/10.1016\/j.smim.2019.101305.","journal-title":"Semin Immunol"},{"issue":"1","key":"15535_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/imr.12519","volume":"276","author":"LP Andrews","year":"2017","unstructured":"Andrews LP, Marciscano AE, Drake CG, Vignali DA. LAG3 (CD223) as a cancer immunotherapy target. Immunol Rev. 2017;276(1):80\u201396. https:\/\/doi.org\/10.1111\/imr.12519.","journal-title":"Immunol Rev"},{"issue":"6","key":"15535_CR20","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1172\/JCI46102","volume":"121","author":"L Baitsch","year":"2011","unstructured":"Baitsch L, Baumgaertner P, Dev\u00eavre E, Raghav SK, Legat A, Barba L, et al. Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients. J Clin Invest. 2011;121(6):2350\u201360. https:\/\/doi.org\/10.1172\/JCI46102.","journal-title":"J Clin Invest"},{"issue":"1","key":"15535_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1158\/2159-8290.CD-14-0863","volume":"5","author":"NJ Llosa","year":"2015","unstructured":"Llosa NJ, Cruise M, Tam A, Wicks EC, Hechenbleikner EM, Taube JM, et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015;5(1):43\u201351. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0863.","journal-title":"Cancer Discov"},{"key":"15535_CR22","doi-asserted-by":"publisher","first-page":"599207","DOI":"10.3389\/fimmu.2021.599207","volume":"12","author":"Q Liu","year":"2021","unstructured":"Liu Q, Qi Y, Zhai J, Kong X, Wang X, Wang Z, et al. Molecular and clinical characterization of LAG3 in breast cancer through 2994 samples. Front Immunol. 2021;12:599207. https:\/\/doi.org\/10.3389\/fimmu.2021.599207.","journal-title":"Front Immunol"},{"issue":"2","key":"15535_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ijc.32785","volume":"147","author":"L Tu","year":"2020","unstructured":"Tu L, Guan R, Yang H, Zhou Y, Hong W, Ma L, et al. Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival. Int J Cancer. 2020;147(2):423\u201339. https:\/\/doi.org\/10.1002\/ijc.32785.","journal-title":"Int J Cancer"},{"key":"15535_CR24","doi-asserted-by":"publisher","first-page":"106113","DOI":"10.1016\/j.intimp.2019.106113","volume":"78","author":"H Du","year":"2020","unstructured":"Du H, Yi Z, Wang L, Li Z, Niu B, Ren G. The co-expression characteristics of LAG3 and PD-1 on the T cells of patients with breast cancer reveal a new therapeutic strategy. Int Immunopharmacol. 2020;78:106113. https:\/\/doi.org\/10.1016\/j.intimp.2019.106113.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"15535_CR25","doi-asserted-by":"publisher","first-page":"e000552","DOI":"10.1136\/jitc-2020-000552","volume":"8","author":"N Kl\u00fcmper","year":"2020","unstructured":"Kl\u00fcmper N, Ralser DJ, Bawden EG, Landsberg J, Zarbl R, Kristiansen G, et al. LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma. J Immunother Cancer. 2020;8(1):e000552. https:\/\/doi.org\/10.1136\/jitc-2020-000552.","journal-title":"J Immunother Cancer"},{"key":"15535_CR26","doi-asserted-by":"publisher","first-page":"102962","DOI":"10.1016\/j.ebiom.2020.102962","volume":"59","author":"A Fr\u00f6hlich","year":"2020","unstructured":"Fr\u00f6hlich A, Sirokay J, Fietz S, Vogt TJ, Dietrich J, Zarbl R, et al. Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma. EBioMedicine. 2020;59:102962. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102962.","journal-title":"EBioMedicine"},{"issue":"2","key":"15535_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/eji.202048753","volume":"51","author":"BJ MacLachlan","year":"2021","unstructured":"MacLachlan BJ, Mason GH, Greenshields-Watson A, Triebel F, Gallimore A, Cole DK, et al. Molecular characterization of HLA class II binding to the LAG-3 T cell co-inhibitory receptor. Eur J Immunol. 2021;51(2):331\u201341. https:\/\/doi.org\/10.1002\/eji.202048753.","journal-title":"Eur J Immunol"},{"issue":"4","key":"15535_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/(SICI)1096-9896(199704)181:4<426::AID-PATH768>3.0.CO;2-T","volume":"181","author":"CA Midgley","year":"1997","unstructured":"Midgley CA, White S, Howitt R, Save V, Dunlop MG, Hall PA, et al. APC expression in normal human tissues. J Pathol. 1997;181(4):426\u201333. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199704)181:4%3c426::AID-PATH768%3e3.0.CO;2-T.","journal-title":"J Pathol"},{"issue":"1","key":"15535_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1006\/excr.2000.5142","volume":"264","author":"JH van Es","year":"2001","unstructured":"van Es JH, Giles RH, Clevers HC. The many faces of the tumor suppressor gene APC. Exp Cell Res. 2001;264(1):126\u201334. https:\/\/doi.org\/10.1006\/excr.2000.5142.","journal-title":"Exp Cell Res"},{"issue":"4","key":"15535_CR30","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/ng1045","volume":"32","author":"MF Kielman","year":"2002","unstructured":"Kielman MF, Rindap\u00e4\u00e4 M, Gaspar C, van Poppel N, Breukel C, van Leeuwen S, et al. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet. 2002;32(4):594\u2013605. https:\/\/doi.org\/10.1038\/ng1045.","journal-title":"Nat Genet"},{"issue":"19","key":"15535_CR31","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.1073\/pnas.91.19.8969","volume":"91","author":"R Fodde","year":"1994","unstructured":"Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B, et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci U S A. 1994;91(19):8969\u201373. https:\/\/doi.org\/10.1073\/pnas.91.19.8969.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"15535_CR32","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1242\/dev.01700","volume":"132","author":"P Andreu","year":"2005","unstructured":"Andreu P, Colnot S, Godard C, Gad S, Chafey P, Niwa-Kawakita M, et al. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development. 2005;132(6):1443\u201351. https:\/\/doi.org\/10.1242\/dev.01700.","journal-title":"Development"},{"issue":"2","key":"15535_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0960-9822(99)80024-4","volume":"9","author":"JH van Es","year":"1999","unstructured":"van Es JH, Kirkpatrick C, van de Wetering M, Molenaar M, Miles A, Kuipers J, et al. Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor. Curr Biol. 1999;9(2):105\u20138. https:\/\/doi.org\/10.1016\/s0960-9822(99)80024-4.","journal-title":"Curr Biol"},{"issue":"12","key":"15535_CR34","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1101\/gad.287404","volume":"18","author":"OJ Sansom","year":"2004","unstructured":"Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP, et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 2004;18(12):1385\u201390. https:\/\/doi.org\/10.1101\/gad.287404.","journal-title":"Genes Dev"},{"issue":"35","key":"15535_CR35","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41388-018-0304-2","volume":"37","author":"AM Mendonsa","year":"2018","unstructured":"Mendonsa AM, Na TY, Gumbiner BM. E-cadherin in contact inhibition and cancer. Oncogene. 2018;37(35):4769\u201380. https:\/\/doi.org\/10.1038\/s41388-018-0304-2.","journal-title":"Oncogene"},{"issue":"42","key":"15535_CR36","doi-asserted-by":"publisher","first-page":"39094","DOI":"10.1074\/jbc.M103450200","volume":"276","author":"AM Carothers","year":"2001","unstructured":"Carothers AM, Melstrom KA Jr, Mueller JD, Weyant MJ, Bertagnolli MM. Progressive changes in adherens junction structure during intestinal adenoma formation in Apc mutant mice. J Biol Chem. 2001;276(42):39094\u2013102. https:\/\/doi.org\/10.1074\/jbc.M103450200.","journal-title":"J Biol Chem"},{"key":"15535_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mdr2.70001","volume":"1","author":"Y Fang","year":"2025","unstructured":"Fang Y, Kong Y, Rong G, Luo Q, Liao W, Zeng D. Systematic investigation of tumor microenvironment and antitumor immunity with IOBR. Med Res. 2025;1:136\u201340. https:\/\/doi.org\/10.1002\/mdr2.70001.","journal-title":"Med Res"},{"issue":"2","key":"15535_CR38","doi-asserted-by":"publisher","first-page":"e010787","DOI":"10.1136\/jitc-2024-010787","volume":"13","author":"P Zhang","year":"2025","unstructured":"Zhang P, Wang D, Zhou G, Jiang S, Zhang G, Zhang L, et al. Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma. J Immunother Cancer. 2025;13(2):e010787. https:\/\/doi.org\/10.1136\/jitc-2024-010787.","journal-title":"J Immunother Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15535-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15535-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15535-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:45:05Z","timestamp":1770723905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15535-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15535"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15535-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"215"}}